Sio Gene Therapies Inc. – NASDAQ:SIOX
Sio Gene Therapies stock price today
$0.415
-0.06
-13.16%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Sio Gene Therapies stock price monthly change
+24.16%
month
Sio Gene Therapies stock price quarterly change
+22.60%
quarter
Sio Gene Therapies stock price yearly change
+4.99%
year
Sio Gene Therapies key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | -0.48 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.57 |
PEG ratio | N/A |
EPS | -0.98 |
Revenue | N/A |
EBITDA | -71.18M |
Income | -71.88M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSio Gene Therapies stock price history
Sio Gene Therapies stock forecast
Sio Gene Therapies financial statements
| Jun 2021 | 0 | -11.87M | |
|---|---|---|---|
| Sep 2021 | 0 | -21.23M | |
| Dec 2021 | 0 | -25.45M | |
| Mar 2022 | 0 | -13.32M |
| Mar 2022 | 75080000 | 14.73M | 19.62% |
|---|---|---|---|
| Jun 2022 | 62482000 | 10.70M | 17.13% |
| Sep 2022 | 53746000 | 4.83M | 8.99% |
| Dec 2022 | 47272000 | 2.15M | 4.55% |
| Jun 2021 | -12.65M | 4.16M | 479K |
|---|---|---|---|
| Sep 2021 | -9.26M | -14K | 0 |
| Dec 2021 | -20.60M | -142K | 962K |
| Mar 2022 | -17.82M | -359K | 0 |
Sio Gene Therapies alternative data
| Aug 2023 | 12 |
|---|---|
| Sep 2023 | 12 |
| Oct 2023 | 12 |
| Nov 2023 | 12 |
| Dec 2023 | 12 |
| Jan 2024 | 12 |
| Feb 2024 | 12 |
| Mar 2024 | 12 |
| Apr 2024 | 12 |
| May 2024 | 12 |
| Jun 2024 | 12 |
| Jul 2024 | 12 |
Sio Gene Therapies other data
3.65%
-21.47%
of SIOX is owned by hedge funds
2.70M
-15.88M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jul 2020 | 47500 | 0 |
| Nov 2020 | 10000 | 0 |
| Mar 2021 | 100000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | CHERUVU PAVAN | Common Stock | 100,000 | $2.48 | $248,200 | ||
Purchase | PANDE ATUL | Common Stock | 10,000 | $2.34 | $23,400 | ||
Purchase | PANDE ATUL | Common Shares | 10,000 | $2.73 | $27,290 | ||
Purchase | CHERUVU PAVAN | Common Shares | 37,500 | $2.74 | $102,638 | ||
Purchase | PANDE ATUL | Common Stock | 10,000 | $1.78 | $17,840 | ||
Purchase | ROIVANT SCIENCES LTD. | Common Shares, par value $0.00001 per share | 5,333,333 | $3.75 | $19,999,999 | ||
Purchase | PANDE ATUL | Common Stock | 3,370 | $5.22 | $17,595 | ||
Purchase | CHERUVU PAVAN | Common Stock | 7,500 | N/A | N/A | ||
Purchase | QVT ASSOCIATES GP LLC | Common Shares, $0.00001 par value per share | 6,666,667 | N/A | N/A | ||
Purchase | VIKING GLOBAL PERFORMANCE LLC | Common Shares, par value $0.00001 per share | 6,666,667 | $1.5 | $10,000,001 |
-
What's the price of Sio Gene Therapies stock today?
One share of Sio Gene Therapies stock can currently be purchased for approximately $0.42.
-
When is Sio Gene Therapies's next earnings date?
Unfortunately, Sio Gene Therapies's (SIOX) next earnings date is currently unknown.
-
Does Sio Gene Therapies pay dividends?
No, Sio Gene Therapies does not pay dividends.
-
What is Sio Gene Therapies's stock symbol?
Sio Gene Therapies Inc. is traded on the NASDAQ under the ticker symbol "SIOX".
-
What is Sio Gene Therapies's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Sio Gene Therapies?
Shares of Sio Gene Therapies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Sio Gene Therapies's key executives?
Sio Gene Therapies's management team includes the following people:
- Dr. Pavan Cheruvu M.D. Chief Executive Officer, Pres & Director(age: 43, pay: $834,770)
- Mr. David W. Nassif Chief Financial Officer, Chief Accounting Officer & Gen. Counsel(age: 71, pay: $671,210)
-
How many employees does Sio Gene Therapies have?
As Jul 2024, Sio Gene Therapies employs 12 workers.
-
When Sio Gene Therapies went public?
Sio Gene Therapies Inc. is publicly traded company for more then 10 years since IPO on 11 Jun 2015.
-
What is Sio Gene Therapies's official website?
The official website for Sio Gene Therapies is siogtx.com.
-
Where are Sio Gene Therapies's headquarters?
Sio Gene Therapies is headquartered at 130 West 42nd Street, New York, NY.
-
How can i contact Sio Gene Therapies?
Sio Gene Therapies's mailing address is 130 West 42nd Street, New York, NY and company can be reached via phone at 877 746 4891.
Sio Gene Therapies company profile:
Sio Gene Therapies Inc.
siogtx.comExchange:
NASDAQ
Full time employees:
12
Industry:
Biotechnology
Sector:
Healthcare
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.
130 West 42nd Street
New York, NY 10036
New York, NY 10036
CIK: 0001636050
ISIN: US8293991043
CUSIP: 829399104
